Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling PathwayRunbin Sun, Guangji Wang|Molecular Pharmacology|2016Cited by 196
The Antihyperglycaemic Activity of Berberine Arises from a Decrease of Glucose AbsorptionGuoyu Pan, Yuanyuan Xie, Guangji Wang et al.|Planta Medica|2003Cited by 137
Inhibition of Metastatic Tumor Growth and Metastasis via Targeting Metastatic Breast Cancer by Chlorotoxin-Modified LiposomesChao Qin, Qiang Zhang, Bing He et al.|Molecular Pharmaceutics|2014Cited by 60
The impact of a chlorotoxin-modified liposome system on receptor MMP-2 and the receptor-associated protein ClC-3Chao Qin, Qiang Zhang, Bing He et al.|Biomaterials|2014Cited by 48
Aberrant branched‐chain amino acid accumulation along the microbiota–gut–brain axis: Crucial targets affecting the occurrence and treatment of ischaemic strokeJiajia Shen, Haiping Hao, Huimin Guo et al.|British Journal of Pharmacology|2022Cited by 48